Literature DB >> 19007054

Probiotics.

Benjamin Kligler1, Andreas Cohrssen.   

Abstract

Probiotics are microorganisms with potential health benefits. They may be used to prevent and treat antibiotic-associated diarrhea and acute infectious diarrhea. They may also be effective in relieving symptoms of irritable bowel syndrome, and in treating atopic dermatitis in children. Species commonly used include Lactobacillus sp., Bifidobacterium sp., Streptococcus thermophilus, and Saccharomyces boulardii. Typical dosages vary based on the product, but common dosages range from 5 to 10 billion colony-forming units per day for children, and from 10 to 20 billion colony-forming units per day for adults. Significant adverse effects are rare, and there are no known interactions with medications.

Entities:  

Mesh:

Year:  2008        PMID: 19007054

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  17 in total

1.  Drying kinetics of probiotic-impregnated murta (Ugni molinae T.) berries.

Authors:  Liliana Zura-Bravo; Angela Rodriguez; Karina Stucken; Antonio Vega-Gálvez
Journal:  J Food Sci Technol       Date:  2018-11-08       Impact factor: 2.701

Review 2.  Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration.

Authors:  Elizabeth A Parker; Tina Roy; Christopher R D'Adamo; L Susan Wieland
Journal:  Nutrition       Date:  2017-07-06       Impact factor: 4.008

Review 3.  Radiation-induced small bowel disease: latest developments and clinical guidance.

Authors:  Rhodri Stacey; John T Green
Journal:  Ther Adv Chronic Dis       Date:  2014-01       Impact factor: 5.091

Review 4.  Antioxidant properties of probiotics and their protective effects in the pathogenesis of radiation-induced enteritis and colitis.

Authors:  Basileios G Spyropoulos; Evangelos P Misiakos; Constantine Fotiadis; Christos N Stoidis
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

5.  Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.

Authors:  Johnathan Sheele; Jessica Cartowski; Angela Dart; Arjun Poddar; Shikha Gupta; Eric Stashko; Bhaskara S Ravi; Crawford Nelson; Ajay Gupta
Journal:  Pathog Glob Health       Date:  2015-08-11       Impact factor: 2.894

6.  In vitro assessment of Enterococcus faecalis MTC 1032 as the potential probiotic in food supplements.

Authors:  Sirikhwan Tinrat; Piyatip Khuntayaporn; Krit Thirapanmethee; Mullika Traidej Chomnawang
Journal:  J Food Sci Technol       Date:  2018-04-26       Impact factor: 2.701

Review 7.  Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.

Authors:  Theresa A Lawrie; John T Green; Mark Beresford; Linda Wedlake; Sorrel Burden; Susan E Davidson; Simon Lal; Caroline C Henson; H Jervoise N Andreyev
Journal:  Cochrane Database Syst Rev       Date:  2018-01-23

Review 8.  Probiotics in dentistry: A boon or sham.

Authors:  Rahul Chopra; Shivani Mathur
Journal:  Dent Res J (Isfahan)       Date:  2013-05

9.  Relationship between the severity of diversion colitis and the composition of colonic bacteria: a prospective study.

Authors:  Se-Jin Baek; Seon-Hahn Kim; Chang-Kyu Lee; Kyoung-Ho Roh; Bora Keum; Chul-Hwan Kim; Jin Kim
Journal:  Gut Liver       Date:  2013-11-05       Impact factor: 4.519

Review 10.  Probiotics in critically ill children.

Authors:  Sunit C Singhi; Suresh Kumar
Journal:  F1000Res       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.